Home » Medical Devices » Mobile Cancer Screening Devices Market

Mobile Cancer Screening Devices Market By Device Type (Portable Ultrasound Device, Mobile Mammography Units, Handheld Biopsy Devices, Telepathology Distribution Channels, Mobile CT Scanners); By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Skin Cancer, Prostate Cancer); By Technology (Imaging Technologies, Biopsy Technologies, Optical Technologies, Genomic Technologies, Liquid Biopsy Technologies); By End User (Hospitals, Diagnostic Laboratories, Research Institutions, Homecare Settings, Mobile Health Units); By Distribution Channel (Direct Sales, Online Sales, Retail Pharmacies, Healthcare Distributors, Third-Party Logistics Providers) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
Mobile Cancer Screening Devices Market Size 2024	USD 3,576.07 million
Mobile Cancer Screening Devices Market, CAGR	8.78%
Mobile Cancer Screening Devices Market Size 2032	USD 6,973.11 million

Market Overview

The Mobile Cancer Screening Devices Market size was valued at USD 2,750.00 million in 2018 to USD 3,576.07 million in 2024 and is anticipated to reach USD 6,973.11 million by 2032, at a CAGR of 8.78 % during the forecast period.

The Mobile Cancer Screening Devices Market is gaining momentum due to the rising global burden of cancer and the growing demand for early, accessible, and cost-effective diagnostic solutions. Governments and healthcare organizations are increasingly deploying mobile screening units in rural and underserved areas to bridge healthcare access gaps and improve cancer detection rates. The portability and rapid deployment of these devices enable timely diagnosis, particularly for breast, cervical, and oral cancers, which are prevalent in low- and middle-income countries. Technological advancements such as AI-powered diagnostics, compact imaging systems, and cloud-based data sharing are enhancing the accuracy and efficiency of mobile screening solutions. Market players are also investing in battery-powered, wireless-enabled devices to facilitate off-grid operations. In addition, partnerships between public health agencies and private manufacturers are accelerating the adoption of mobile cancer screening programs. These trends reflect a broader shift toward preventive healthcare and decentralization of diagnostic services, supporting market expansion across both developed and emerging economies.

The Mobile Cancer Screening Devices Market spans key regions including North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America holds the largest share due to advanced healthcare infrastructure and strong government support, while Europe follows with widespread adoption of national screening programs. Asia Pacific is the fastest-growing region, driven by rising cancer incidence and expanding rural healthcare access. Latin America, the Middle East, and Africa are experiencing steady growth through public health initiatives and mobile outreach programs. Major players in the market include MobileODT Ltd., Niramai Health Analytix, UE LifeSciences, Forward Science, Braster S.A., TruScreen, Breastlight, Bremed Ltd., and AbDent. These companies focus on innovation in portable diagnostics, AI integration, and strategic partnerships to improve accessibility and early detection in both developed and emerging markets.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights

The Mobile Cancer Screening Devices Market was valued at USD 2,750.00 million in 2018, reached USD 3,576.07 million in 2024, and is projected to hit USD 6,973.11 million by 2032, growing at a CAGR of 8.78%.
Rising global cancer prevalence and the need for early, cost-effective diagnostics are accelerating the demand for mobile screening solutions, especially in low- and middle-income regions.
Healthcare systems are increasingly adopting mobile units to bridge access gaps in underserved rural areas, enabling timely diagnosis for cancers like breast, cervical, and oral.
Technological advancements such as AI-integrated imaging, compact diagnostics, and cloud-based platforms are enhancing accuracy, mobility, and real-time data sharing capabilities.
North America holds the largest regional market share, followed by Europe, while Asia Pacific emerges as the fastest-growing region driven by large populations and expanded rural outreach
Latin America, the Middle East, and Africa are witnessing steady growth fueled by public health campaigns, international collaborations, and NGO-supported screening initiatives
Key players including MobileODT Ltd., Niramai Health Analytix, UE LifeSciences, Forward Science, Braster S.A., TruScreen, Breastlight, Bremed Ltd., and AbDent are focusing on innovation, affordability, and strategic partnerships to boost global adoption.

Market Drivers

Rising Global Cancer Burden and Demand for Early Detection

The increasing incidence of cancer worldwide is a major factor driving the Mobile Cancer Screening Devices Market. Governments and healthcare providers recognize the importance of early detection in reducing mortality rates and improving treatment outcomes. It supports timely intervention, particularly in resource-limited settings where traditional screening infrastructure is lacking. The growing awareness about preventive healthcare practices is also expanding patient participation in mobile screening programs. It allows access to diagnostics in remote areas.

For instance, Deos Consultancy and WH Bence Coachworks (UK) offer mobile breast screening with digital imaging sent to hospitals in under three minutes.

Healthcare Accessibility in Underserved Regions

Limited access to hospitals and diagnostic centers in rural and low-income regions fuels the need for mobile screening solutions. The Mobile Cancer Screening Devices Market addresses these challenges by offering portable, self-contained units capable of reaching patients in distant locations. It enables on-site cancer detection services, reducing the burden of travel and associated healthcare costs. Governments and NGOs are deploying mobile units to target underserved populations, strengthening early-stage diagnosis and cancer awareness. The approach improves population health equity.

For instance, In India, the “Pink Chain” initiative has used portable breast screening devices to reach thousands of women in remote areas, significantly improving early detection rates and reducing the need for travel to urban hospitals.

Technological Innovations in Portable Diagnostic Equipment

Continuous innovation in imaging technologies and diagnostic software contributes to the growth of the Mobile Cancer Screening Devices Market. Advancements in AI integration, compact ultrasound, digital mammography, and cloud-based data systems are enhancing diagnostic accuracy and speed. It enables real-time analysis and data sharing with specialists, even in isolated regions. Manufacturers are developing lightweight, battery-operated devices tailored for mobile deployment. These features support quick setup, minimal power requirements, and easy transportation across varying terrain and climates.

Government Initiatives and Public-Private Partnerships

Public health agencies and global health organizations are increasing investments in mobile screening initiatives to address healthcare disparities. The Mobile Cancer Screening Devices Market benefits from favorable policies, subsidies, and funding aimed at improving diagnostic outreach. It gains traction through collaborations between healthcare providers, technology firms, and nonprofit organizations. These partnerships facilitate training, equipment deployment, and data collection, strengthening public health infrastructure. Regulatory support also simplifies device approval processes and accelerates market entry.

Market Trends

Integration of Artificial Intelligence and Cloud Connectivity

The integration of artificial intelligence and cloud-based platforms is transforming diagnostic capabilities in the Mobile Cancer Screening Devices Market. AI algorithms assist in image analysis, reducing human error and improving diagnostic accuracy. Cloud connectivity allows instant data transmission to centralized healthcare systems, enabling expert consultations without delays. It facilitates continuity of care by maintaining secure patient records. These technologies support efficient workflows and enhance decision-making in remote or resource-constrained settings where specialists are scarce.

For instance, Grail’s Galleri® blood test uses AI to detect over 50 cancer types early, enabling remote diagnostics via cloud connectivity.

Shift Toward Compact and Battery-Operated Screening Devices

Manufacturers are prioritizing the development of compact, lightweight, and battery-powered cancer screening equipment tailored for mobile applications. The Mobile Cancer Screening Devices Market is evolving with devices that require minimal infrastructure and can operate without constant power supply. It helps in deploying screening services to off-grid rural zones and disaster-affected regions. Improved mobility and simplified setup reduce operational barriers. These user-friendly devices enhance outreach capacity while maintaining accuracy and clinical reliability in the field.

For instance, The CITEC consortium led by Rice University creates compact devices for early cancer detection in underserved areas.

Growth of Mobile Screening Programs in Emerging Markets

Emerging economies are increasingly adopting mobile screening initiatives to counter limited healthcare access and high cancer prevalence. The Mobile Cancer Screening Devices Market sees strong uptake in regions like Southeast Asia, Africa, and Latin America, where mobile health units play a critical role in public health. It enables targeted campaigns focusing on cervical, breast, and oral cancer screening. Governments and NGOs are scaling efforts through mobile outreach, boosting awareness and early detection rates. The trend supports broader public health goals.

Rising Demand for Multi-Cancer Detection Platforms

The market is witnessing a growing trend toward multi-cancer detection platforms within a single mobile unit. The Mobile Cancer Screening Devices Market is incorporating tools that screen for multiple cancer types during one visit, improving cost efficiency and patient compliance. It maximizes resource utilization while minimizing the need for multiple appointments. This trend supports holistic community health programs and helps providers manage increasing screening demands. It also fosters integration across screening, diagnostics, and referral systems

Market Challenges Analysis

Infrastructure and Logistical Barriers in Remote Deployment

The Mobile Cancer Screening Devices Market faces significant challenges related to transportation, maintenance, and technical support in remote or underserved regions. Many rural areas lack basic road infrastructure, stable electricity, and internet connectivity, complicating the deployment and operation of mobile units. It requires specialized planning to ensure consistent service delivery and reliable communication with healthcare networks. Technical breakdowns and delays in servicing can disrupt screening schedules and affect patient outcomes. Ensuring safe storage and calibration of sensitive diagnostic equipment during travel remains difficult. These logistical constraints hinder scalability and consistent access to screening services.

Limited Skilled Workforce and Diagnostic Follow-up Capacity

A shortage of trained healthcare professionals capable of operating mobile diagnostic systems and interpreting results is a critical barrier. The Mobile Cancer Screening Devices Market depends heavily on staff proficiency to ensure accurate screenings and patient counseling. It struggles in areas where health workers lack the necessary training or resources to manage screening data and coordinate follow-ups. In many regions, healthcare systems remain fragmented, delaying referrals and treatment initiation after initial diagnosis. This gap undermines the effectiveness of early detection. Long-term success requires investments in workforce development and integrated care pathways.

Market Opportunities

Expansion of Mobile Health in Low-Resource Settings

The Mobile Cancer Screening Devices Market holds strong potential in low- and middle-income countries where healthcare infrastructure remains limited. Governments and global health organizations are increasing focus on mobile health initiatives to bridge access gaps and improve early detection rates. It presents a valuable opportunity for manufacturers to design cost-effective, durable, and easy-to-operate devices tailored to field conditions. Expanding mobile services aligns with public health goals, including reducing cancer-related mortality through early intervention. Demand for scalable solutions continues to grow in rural and peri-urban areas. Targeted deployment can significantly boost screening coverage and health outcomes.

Public-Private Partnerships and Innovation-Driven Models

Collaborations between technology companies, NGOs, and government agencies are unlocking new channels for market growth. The Mobile Cancer Screening Devices Market benefits from models that integrate diagnostic technology with data management, cloud systems, and remote consultations. It encourages investment in research and development to support AI-powered diagnostics, telemedicine, and modular platforms. Partnerships help address funding challenges, streamline deployment, and improve care coordination. There is also growing scope to license or co-develop screening technologies for local markets. These opportunities support both commercial success and long-term public health impact.

Market Segmentation Analysis:

By Device Type

The Mobile Cancer Screening Devices Market is segmented into portable ultrasound devices, mobile mammography units, handheld biopsy devices, telepathology distribution channels, and mobile CT scanners. Mobile mammography units lead the segment due to high demand for breast cancer screening. Portable ultrasound devices are gaining momentum in rural and remote applications because of their flexibility and cost-effectiveness. Handheld biopsy tools enable tissue sampling on-site, improving diagnostic speed. Mobile CT scanners and telepathology solutions support complex assessments in underserved regions.

For instance, the American Italian Cancer Foundation’s Mobile, No-Cost Breast Cancer Screening Program in New York City provided clinical breast exams and mammograms to women aged 40–79 who had not been screened in the previous year, directly reaching underserved communities.

By Cancer Type

The Mobile Cancer Screening Devices Market addresses multiple cancer types including breast, lung, colorectal, skin, and prostate cancers. Breast cancer holds the largest share due to strong public health campaigns and early detection efforts. Lung and colorectal cancers are growing segments, driven by rising incidence and support for population-based screening. Skin cancer devices are gaining adoption in high-risk regions. Prostate cancer screening is expanding with the use of portable diagnostics and improved awareness.

For instance, in Nigeria, a study comparing iBreastExam to clinical breast examination found that iBreastExam had a sensitivity of 63% versus 31% for detecting any breast finding, and both methods detected 87% of biopsy-confirmed cancers in symptomatic women.

By Technology

Technologies in the Mobile Cancer Screening Devices Market include imaging, biopsy, optical, genomic, and liquid biopsy methods. Imaging technologies dominate due to their widespread use in ultrasound, mammography, and CT applications. Biopsy and optical tools provide targeted analysis and tissue examination, supporting fast diagnosis. Genomic technologies are emerging in mobile setups through simplified platforms. Liquid biopsy innovations are increasing due to their non-invasive nature and potential for early detection through blood-based markers.

Segments:

Based on Device Type:

Portable Ultrasound Device
Mobile Mammography Units
Handheld Biopsy Devices
Telepathology Distribution Channels
Mobile CT Scanners

Based on Cancer Type:

Breast Cancer
Lung Cancer
Colorectal Cancer
Skin Cancer
Prostate Cancer

Based on Technology:

Imaging Technologies
Biopsy Technologies
Optical Technologies
Genomic Technologies
Liquid Biopsy Technologies

Based on End User:

Hospitals
Diagnostic Laboratories
Research Institutions
Homecare Settings
Mobile Health Units

Based on Distribution Channel:

Direct Sales
Online Sales
Retail Pharmacies
Healthcare Distributors
Third-Party Logistics Providers

Based on Region:

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

Regional Analysis

North America

The North America Mobile Cancer Screening Devices Market size was valued at USD 1,106.88 million in 2018 to USD 1,423.61 million in 2024 and is anticipated to reach USD 2,772.52 million by 2032, at a CAGR of 8.8% during the forecast period. North America holds the largest market share due to robust healthcare infrastructure, high awareness levels, and strong government support for cancer screening programs. The United States dominates the region, with mobile mammography and CT units deployed in both urban and rural areas. It benefits from early adoption of advanced technologies such as AI-enabled diagnostics and telepathology. Canada and Mexico are expanding access through mobile outreach initiatives. Strategic collaborations between public health agencies and private device manufacturers further support market penetration.

Europe

The Europe Mobile Cancer Screening Devices Market size was valued at USD 553.30 million in 2018 to USD 682.93 million in 2024 and is anticipated to reach USD 1,233.91 million by 2032, at a CAGR of 7.8% during the forecast period. Europe ranks second in global share, driven by national screening programs and strong regulatory frameworks. Countries such as Germany, France, and the UK are investing in mobile mammography and colorectal cancer screening solutions. It benefits from EU-wide health strategies focused on preventive care and reducing cancer mortality. Mobile units are helping reach underserved communities and aging populations. Continued investments in digital pathology and cloud-connected diagnostics are strengthening market performance.

Asia Pacific

The Asia Pacific Mobile Cancer Screening Devices Market size was valued at USD 705.93 million in 2018 to USD 956.76 million in 2024 and is anticipated to reach USD 2,050.10 million by 2032, at a CAGR of 10.1% during the forecast period. Asia Pacific is the fastest-growing region, driven by rising cancer burden, expanding healthcare access, and government-led screening initiatives. Countries like China, India, and Japan are deploying mobile health units to underserved rural populations. It sees rising demand for cost-effective, portable diagnostic tools across breast, cervical, and lung cancers. Public-private partnerships and growing investments in telemedicine are fueling adoption. The region’s population size and policy focus on early detection create strong long-term potential.

Latin America

The Latin America Mobile Cancer Screening Devices Market size was valued at USD 186.45 million in 2018 to USD 240.28 million in 2024 and is anticipated to reach USD 437.00 million by 2032, at a CAGR of 7.9% during the forecast period. Latin America is gaining traction through initiatives targeting healthcare inequality and early cancer detection. Brazil, Mexico, and Argentina are leading deployments of mobile units, especially in regions with limited hospital infrastructure. It supports rural outreach and screening awareness campaigns. Mobile mammography and ultrasound technologies are the most in demand. Collaborations with NGOs and international health organizations are driving regional expansion. Despite challenges in logistics and workforce availability, mobile diagnostics are showing promising outcomes.

Middle East

The Middle East Mobile Cancer Screening Devices Market size was valued at USD 107.80 million in 2018 to USD 131.58 million in 2024 and is anticipated to reach USD 232.24 million by 2032, at a CAGR of 7.5% during the forecast period. The Middle East shows steady growth due to increasing investments in health infrastructure and focus on non-communicable disease management. Gulf Cooperation Council (GCC) countries are leading the adoption of mobile cancer screening programs. It emphasizes early detection and screening for breast and colorectal cancers. Governments are launching health awareness drives and expanding mobile health fleets. Israel and Turkey are investing in telemedicine integration and AI-driven diagnostic tools. Regional efforts align with national healthcare transformation plans.

Africa

The Africa Mobile Cancer Screening Devices Market size was valued at USD 89.65 million in 2018 to USD 140.91 million in 2024 and is anticipated to reach USD 247.33 million by 2032, at a CAGR of 7.0% during the forecast period. Africa presents strong opportunities for mobile screening due to limited access to centralized healthcare facilities. Countries like South Africa, Kenya, and Egypt are launching community-based outreach programs using mobile diagnostics. It addresses challenges in early detection of cervical, breast, and skin cancers. Local governments and NGOs are driving awareness and resource allocation. Infrastructure gaps and workforce limitations persist but innovation in portable technologies is helping overcome barriers. Mobile units serve as vital tools in national cancer control strategies.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

AbDent
Breastlight
Braster S.A.
Bremed Ltd.
Forward Science
MobileODT Ltd.
Niramai Health Analytix
TruScreen
UE LifeSciences

Competitive Analysis

The Mobile Cancer Screening Devices Market is characterized by moderate fragmentation with the presence of both established medical device companies and specialized startups. Key players compete on technology innovation, portability, diagnostic accuracy, and ease of deployment. It includes firms like MobileODT Ltd., Niramai Health Analytix, UE LifeSciences, and Forward Science, which focus on AI-driven and non-invasive technologies. Larger manufacturers often form partnerships with public health agencies to expand reach into low-resource regions. Companies are investing in R&D to integrate imaging, biopsy, and data-sharing capabilities into compact mobile platforms. The market is witnessing strategic collaborations, product launches, and regional expansions aimed at enhancing accessibility and clinical outcomes. Players also differentiate through customization for local health conditions and regulatory compliance. The competitive landscape continues to evolve with rising demand for scalable, field-ready solutions that align with global cancer prevention efforts.

Recent Developments

In March 2025, Fujifilm launched the NURA Express mobile health screening bus in Kerala, India, offering on-site CT scans for cancer and lifestyle diseases with remote image interpretation.
In October 2023, Niramai Health Analytix partnered with Molbio Diagnostics to strengthen breast cancer screening programs across underserved regions in India.
In December 2024, UE LifeSciences announced the upcoming RaKSA initiative, which combines iBreastExam, cervAIcal, and OrCA into a single program to detect breast, cervical, and oral cancers at 40,000 primary health centers in India.
In March 2023, MobileODT and GenWorks launched the ThermoGlide device in India, offering a portable, FDA-approved cervical screening and treatment solution.

Market Concentration & Characteristics

The Mobile Cancer Screening Devices Market demonstrates moderate concentration, with a mix of global diagnostic firms and emerging technology startups shaping its competitive structure. It features companies that specialize in portable imaging, AI-based diagnostics, and handheld biopsy tools. The market is innovation-driven, with firms focusing on developing lightweight, battery-operated, and cloud-connected devices to enable field diagnostics. It favors companies that offer scalable, user-friendly technologies compatible with mobile health infrastructure. Strategic collaborations with government agencies, NGOs, and public health programs are common, allowing manufacturers to extend geographic reach and address infrastructure limitations. The market shows strong responsiveness to advancements in telemedicine, artificial intelligence, and compact diagnostic hardware. Regulatory environments in high-growth regions like Asia Pacific and Latin America encourage adoption of mobile solutions to fill access gaps. It also favors players capable of adapting to diverse clinical settings and local needs, making flexibility and affordability critical characteristics in product design and distribution strategies.

Report Coverage

The research report offers an in-depth analysis based on Device Type, Cancer Type, Technology, End-User, Distribution Channel and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

Mobile cancer screening devices will see wider deployment in rural and underserved areas to improve early diagnosis rates.
Governments are expected to increase funding for mobile health programs targeting cancer detection.
Technological advancements will lead to more compact, AI-integrated, and battery-powered screening solutions.
Demand for multi-cancer screening platforms in a single unit will continue to grow.
Public-private partnerships will expand to support large-scale community screening initiatives.
Integration with telemedicine platforms will improve diagnostic accuracy and follow-up care.
Companies will focus on cost-effective models to meet the needs of low- and middle-income countries.
Data connectivity and cloud storage capabilities will become standard in mobile screening devices.
Regional markets in Asia Pacific, Latin America, and Africa will present high-growth opportunities.
Regulatory support and faster device approvals will encourage innovation and market expansion.

CHAPTER NO. 1 : GENESIS OF THE MARKET

1.1 Market Prelude – Introduction & Scope

1.2 The Big Picture – Objectives & Vision

1.3 Strategic Edge – Unique Value Proposition

1.4 Stakeholder Compass – Key Beneficiaries

CHAPTER NO. 2 : EXECUTIVE LENS

2.1 Pulse of the Industry – Market Snapshot

2.2 Growth Arc – Revenue Projections (USD Million)

2.3. Premium Insights – Based on Primary Interviews

CHAPTER NO. 3 : MOBILE CANCER SCREENING DEVICES MARKET FORCES & INDUSTRY PULSE

3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown

3.6 Price Trend Analysis

3.6.1 Regional Price Trend
3.6.2 Price Trend by product

CHAPTER NO. 4 : KEY INVESTMENT EPICENTER

4.1 Regional Goldmines – High-Growth Geographies

4.2 Product Frontiers – Lucrative Product Categories

4.3 Cancer Type Sweet Spots – Emerging Demand Segments

CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING

5.1 Momentum Metrics – Forecast & Growth Curves

5.2 Regional Revenue Footprint – Market Share Insights

5.3 Segmental Wealth Flow – Device Type & Cancer Type Revenue

CHAPTER NO. 6 : TRADE & COMMERCE ANALYSIS

6.1. Import Analysis by Region

6.1.1. Global Mobile Cancer Screening Devices Market Import Revenue By Region

6.2. Export Analysis by Region

6.2.1. Global Mobile Cancer Screening Devices Market Export Revenue By Region

CHAPTER NO. 7 : COMPETITION ANALYSIS

7.1. Company Market Share Analysis

7.1.1. Global Mobile Cancer Screening Devices Market: Company Market Share

7.2. Global Mobile Cancer Screening Devices Market Company Revenue Market Share

7.3. Strategic Developments

7.3.1. Acquisitions & Mergers

7.3.2. New Product Launch

7.3.3. Regional Expansion

7.4. Competitive Dashboard

7.5. Company Assessment Metrics, 2024

CHAPTER NO. 8 : MOBILE CANCER SCREENING DEVICES MARKET – BY DEVICE TYPE SEGMENT ANALYSIS

8.1. Mobile Cancer Screening Devices Market Overview by Device Type Segment

8.1.1. Mobile Cancer Screening Devices Market Revenue Share By Device Type

8.2. Portable Ultrasound Devices

8.3. Mobile Mammography Units

8.4. Handheld Biopsy Devices

8.5. Telepathology Distribution Channels

8.6. Mobile CT Scanners

CHAPTER NO. 9 : MOBILE CANCER SCREENING DEVICES MARKET – BY CANCER TYPE SEGMENT ANALYSIS

9.1. Mobile Cancer Screening Devices Market Overview by Cancer Type Segment

9.1.1. Mobile Cancer Screening Devices Market Revenue Share By Cancer Type

9.2. Breast Cancer

9.3. Lung Cancer

9.4. Colorectal Cancer

9.5. Skin Cancer

9.6. Prostate Cancer

CHAPTER NO. 10 : MOBILE CANCER SCREENING DEVICES MARKET – BY TECHNOLOGY SEGMENT ANALYSIS

10.1. Mobile Cancer Screening Devices Market Overview by Technology Segment

10.1.1. Mobile Cancer Screening Devices Market Revenue Share By Technology

10.2. Imaging Technologies

10.3. Biopsy Technologies

10.4. Optical Technologies

10.5. Genomic Technologies

10.6. Liquid Biopsy Technologies

CHAPTER NO. 11 : MOBILE CANCER SCREENING DEVICES MARKET – BY END USER SEGMENT ANALYSIS

11.1. Mobile Cancer Screening Devices Market Overview by End User Segment

11.1.1. Mobile Cancer Screening Devices Market Revenue Share By End User

11.2. Hospitals

11.3. Diagnostic Laboratories

11.4. Research Institutions

11.5. Homecare Settings

11.6. Mobile Health Units

CHAPTER NO. 12 : MOBILE CANCER SCREENING DEVICES MARKET – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS

12.1. Mobile Cancer Screening Devices Market Overview by Distribution Channel Segment

12.1.1. Mobile Cancer Screening Devices Market Revenue Share By Distribution Channel

12.2. Direct Sales

12.3. Online Sales

12.4. Retail Pharmacies

12.5. Healthcare Distributors

12.6. Third-Party Logistics Providers

CHAPTER NO. 13 : MOBILE CANCER SCREENING DEVICES MARKET – REGIONAL ANALYSIS

13.1. Mobile Cancer Screening Devices Market Overview by Region Segment

13.1.1. Global Mobile Cancer Screening Devices Market Revenue Share By Region

13.1.2. Regions

13.1.3. Global Mobile Cancer Screening Devices Market Revenue By Region

13.1.4. Device Type

13.1.5. Global Mobile Cancer Screening Devices Market Revenue By Device Type

13.1.6. Cancer Type

13.1.7. Global Mobile Cancer Screening Devices Market Revenue By Cancer Type

13.1.8. Technology

13.1.9. Global Mobile Cancer Screening Devices Market Revenue By Technology

13.1.10. End User

13.1.12. Global Mobile Cancer Screening Devices Market Revenue By End User

13.1.13. Distribution Channel

13.1.14. Global Mobile Cancer Screening Devices Market Revenue By Distribution Channel

CHAPTER NO. 14 : NORTH AMERICA MOBILE CANCER SCREENING DEVICES MARKET – COUNTRY ANALYSIS

14.1. North America Mobile Cancer Screening Devices Market Overview by Country Segment

14.1.1. North America Mobile Cancer Screening Devices Market Revenue Share By Region

14.2. North America

14.2.1. North America Mobile Cancer Screening Devices Market Revenue By Country

14.2.2. Device Type

14.2.3. North America Mobile Cancer Screening Devices Market Revenue By Device Type

14.2.4. Cancer Type

14.2.5. North America Mobile Cancer Screening Devices Market Revenue By Cancer Type

14.2.6. Technology

14.2.7. North America Mobile Cancer Screening Devices Market Revenue By Technology

14.2.8. End User

14.2.9. North America Mobile Cancer Screening Devices Market Revenue By End User

14.2.10. Distribution Channel

14.2.11. North America Mobile Cancer Screening Devices Market Revenue By Distribution Channel

14.3. U.S.

14.4. Canada

14.5. Mexico

CHAPTER NO. 15 : EUROPE MOBILE CANCER SCREENING DEVICES MARKET – COUNTRY ANALYSIS

15.1. Europe Mobile Cancer Screening Devices Market Overview by Country Segment

15.1.1. Europe Mobile Cancer Screening Devices Market Revenue Share By Region

15.2. Europe

15.2.1. Europe Mobile Cancer Screening Devices Market Revenue By Country

15.2.2. Device Type

15.2.3. Europe Mobile Cancer Screening Devices Market Revenue By Device Type

15.2.4. Cancer Type

15.2.5. Europe Mobile Cancer Screening Devices Market Revenue By Cancer Type

15.2.6. Technology

15.2.7. Europe Mobile Cancer Screening Devices Market Revenue By Technology

15.2.8. End User

15.2.9. Europe Mobile Cancer Screening Devices Market Revenue By End User

15.2.10. Distribution Channel

15.2.11. Europe Mobile Cancer Screening Devices Market Revenue By Distribution Channel

15.3. UK

15.4. France

15.5. Germany

15.6. Italy

15.7. Spain

15.8. Russia

15.9. Rest of Europe

CHAPTER NO. 16 : ASIA PACIFIC MOBILE CANCER SCREENING DEVICES MARKET – COUNTRY ANALYSIS

16.1. Asia Pacific Mobile Cancer Screening Devices Market Overview by Country Segment

16.1.1. Asia Pacific Mobile Cancer Screening Devices Market Revenue Share By Region

16.2. Asia Pacific

16.2.1. Asia Pacific Mobile Cancer Screening Devices Market Revenue By Country

16.2.2. Device Type

16.2.3. Asia Pacific Mobile Cancer Screening Devices Market Revenue By Device Type

16.2.4. Cancer Type

16.2.5. Asia Pacific Mobile Cancer Screening Devices Market Revenue By Cancer Type

16.2.6. Technology

16.2.7. Asia Pacific Mobile Cancer Screening Devices Market Revenue By Technology

16.2.8. End User

16.2.9. Asia Pacific Mobile Cancer Screening Devices Market Revenue By End User

16.2.10. Distribution Channel

16.2.11. Asia Pacific Mobile Cancer Screening Devices Market Revenue By Distribution Channel

16.3. China

16.4. Japan

16.5. South Korea

16.6. India

16.7. Australia

16.8. Southeast Asia

16.9. Rest of Asia Pacific

CHAPTER NO. 17 : LATIN AMERICA MOBILE CANCER SCREENING DEVICES MARKET – COUNTRY ANALYSIS

17.1. Latin America Mobile Cancer Screening Devices Market Overview by Country Segment

17.1.1. Latin America Mobile Cancer Screening Devices Market Revenue Share By Region

17.2. Latin America

17.2.1. Latin America Mobile Cancer Screening Devices Market Revenue By Country

17.2.2. Device Type

17.2.3. Latin America Mobile Cancer Screening Devices Market Revenue By Device Type

17.2.4. Cancer Type

17.2.5. Latin America Mobile Cancer Screening Devices Market Revenue By Cancer Type

17.2.6. Technology

17.2.7. Latin America Mobile Cancer Screening Devices Market Revenue By Technology

17.2.8. End User

17.2.9. Latin America Mobile Cancer Screening Devices Market Revenue By End User

17.2.10. Distribution Channel

17.2.11. Latin America Mobile Cancer Screening Devices Market Revenue By Distribution Channel

17.3. Brazil

17.4. Argentina

17.5. Rest of Latin America

CHAPTER NO. 18 : MIDDLE EAST MOBILE CANCER SCREENING DEVICES MARKET – COUNTRY ANALYSIS

18.1. Middle East Mobile Cancer Screening Devices Market Overview by Country Segment

18.1.1. Middle East Mobile Cancer Screening Devices Market Revenue Share By Region

18.2. Middle East

18.2.1. Middle East Mobile Cancer Screening Devices Market Revenue By Country

18.2.2. Device Type

18.2.3. Middle East Mobile Cancer Screening Devices Market Revenue By Device Type

18.2.4. Cancer Type

18.2.5. Middle East Mobile Cancer Screening Devices Market Revenue By Cancer Type

18.2.6. Technology

18.2.7. Middle East Mobile Cancer Screening Devices Market Revenue By Technology

18.2.8. End User

18.2.9. Middle East Mobile Cancer Screening Devices Market Revenue By End User

18.2.10. Distribution Channel

18.2.11. Middle East Mobile Cancer Screening Devices Market Revenue By Distribution Channel

18.3. GCC Countries

18.4. Israel

18.5. Turkey

18.6. Rest of Middle East

CHAPTER NO. 19 : AFRICA MOBILE CANCER SCREENING DEVICES MARKET – COUNTRY ANALYSIS

19.1. Africa Mobile Cancer Screening Devices Market Overview by Country Segment

19.1.1. Africa Mobile Cancer Screening Devices Market Revenue Share By Region

19.2. Africa

19.2.1. Africa Mobile Cancer Screening Devices Market Revenue By Country

19.2.2. Device Type

19.2.3. Africa Mobile Cancer Screening Devices Market Revenue By Device Type

19.2.4. Cancer Type

19.2.5. Africa Mobile Cancer Screening Devices Market Revenue By Cancer Type

19.2.6. Technology

19.2.7. Africa Mobile Cancer Screening Devices Market Revenue By Technology

19.2.8. End User

19.2.9. Africa Mobile Cancer Screening Devices Market Revenue By End User

19.2.10. Distribution Channel

19.2.11. Africa Mobile Cancer Screening Devices Market Revenue By Distribution Channel

19.3. South Africa

19.4. Egypt

19.5. Rest of Africa

CHAPTER NO. 20 : COMPANY PROFILES

20.1. AbDent

20.1.1. Company Overview

20.1.2. Product Portfolio

20.1.3. Financial Overview

20.1.4. Recent Developments

20.1.5. Growth Strategy

20.1.6. SWOT Analysis

20.2. Breastlight

20.3. Braster S.A.

20.4. Bremed Ltd.

20.5. Forward Science

20.6. MobileODT Ltd.

20.7. Niramai Health Analytix

20.8. TruScreen

20.9. UE LifeSciences

Frequently Asked Questions:

What is the current size of the Mobile Cancer Screening Devices Market?

The market was valued at USD 3,576.07 million in 2024 and is expected to reach USD 6,973.11 million by 2032, showing strong growth.

What are the key segments within the Mobile Cancer Screening Devices Market?

The market segments include device type, cancer type, technology, end user, and distribution channel, with mobile mammography and breast cancer screening leading global demand.

What are some challenges faced by the Mobile Cancer Screening Devices Market?

Challenges include poor infrastructure, limited skilled personnel, device servicing issues, fragmented healthcare systems, and difficulty in ensuring timely follow-up care in remote and rural areas.

Who are the major players in the Mobile Cancer Screening Devices Market?

Major companies include MobileODT, Niramai, UE LifeSciences, Forward Science, Braster
S.A., TruScreen, Breastlight, Bremed Ltd., and AbDent, focusing on innovative
and portable diagnostic technologies.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Reviewed By
Gunakesh Parmar

Research Consultant

With over 15 years of dedicated experience in market research since 2009, specializes in delivering actionable insights from data.

View Profile

Purchase Options

Single User

$4699

Multi User

$5699

Custom Report

$12699

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –